Nørsett et al., 2011 - Google Patents
Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cellsNørsett et al., 2011
View HTML- Document ID
- 1307293663161240580
- Author
- Nørsett K
- Steele I
- Duval C
- Sammut S
- Murugesan S
- Kenny S
- Rainbow L
- Dimaline R
- Dockray G
- Pritchard D
- Varro A
- Publication year
- Publication venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
External Links
Snippet
Plasminogen activator inhibitor (PAI)-1 is associated with cancer progression, fibrosis and thrombosis. It is expressed in the stomach but the mechanisms controlling its expression there, and its biological role, are uncertain. We sought to define the role of gastrin in …
- 102000012335 Plasminogen Activator Inhibitor 1 0 title abstract description 99
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nørsett et al. | Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells | |
Liu et al. | ZIP4 promotes pancreatic cancer progression by repressing ZO-1 and claudin-1 through a ZEB1-dependent transcriptional mechanism | |
Sims-Mourtada et al. | Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response | |
Mujcic et al. | Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3 | |
Joyce et al. | Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis | |
Nagoshi | Osteopontin: Versatile modulator of liver diseases | |
Su et al. | The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies | |
Zhang et al. | Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9 | |
Davies et al. | Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion | |
Samani et al. | The role of the IGF system in cancer growth and metastasis: overview and recent insights | |
Said et al. | Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer | |
Juillerat-Jeanneret et al. | Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma | |
Mohanty et al. | STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer | |
Zhang et al. | PKM2 released by neutrophils at wound site facilitates early wound healing by promoting angiogenesis | |
He et al. | REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP‐7 and MMP‐9 | |
Tilli et al. | Both osteopontin‐c and osteopontin‐b splicing isoforms exert pro‐tumorigenic roles in prostate cancer cells | |
Bauer et al. | Insulinlike growth factor-i–mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor | |
Zhang et al. | Overexpression of methionine adenosyltransferase II alpha (MAT2A) in gastric cancer and induction of cell cycle arrest and apoptosis in SGC-7901 cells by shRNA-mediated silencing of MAT2A gene | |
Nouguerède et al. | RETRACTED: Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo | |
Li et al. | PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1 | |
Golovine et al. | Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-κB and reduces the malignant potential of prostate cancer cells in vitro and in vivo | |
Pulliam et al. | Regulation and role of CAMKK2 in prostate cancer | |
Lin et al. | Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma | |
Zhang et al. | LRP6 ectodomain prevents SDF-1/CXCR4-induced breast cancer metastasis to lung | |
Muhammad et al. | The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target |